CSL Behring (Portugal)

CSL Behring is a global biotechnology company specializing in the development and manufacture of plasma-derived and recombinant therapies for rare and serious diseases. The Portugal entity functions as a local subsidiary of the Australian-headquartered parent corporation, CSL Limited, focusing on the distribution and commercialization of these pharmaceutical products.